MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference32 articles.
1. Triple-negative breast cancer;RD Chacon;Breast Cancer Res,2010
2. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment;Y Gao;Cell Physiol Biochem,2016
3. The epigenomics of cancer;PA Jones;Cell,2007
4. Cancer genomics identifies disrupted epigenetic genes;L Simo-Riudalbas;Hum Genet,2014
5. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer;M Spitzwieser;Breast Cancer Res,2015
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance;International Journal of Molecular Sciences;2024-08-21
2. Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial;Scientific Reports;2023-12-04
3. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients;International Journal of Molecular Sciences;2023-12-02
4. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine;EPMA Journal;2023-05-22
5. DNA methylation and breast cancer: A way forward (Review);International Journal of Oncology;2021-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3